BioSpace News Archive

KSQ Therapeutics announced the appointment of Beni B. Wolf, MD, PhD, as Chief Medical Officer.

OnCall’s platform improves access to healthcare for patients consulting with mental health, primary care, medical cannabis, pharmaceutical and disability insurance industries.

Lisa Shafer, Ph.D., Chief Scientific Officer, and Eric Distad, Vice President of Clinical Development, add Extensive CNS Drug-Device Development Experience

The world’s largest online marketplace rolls out first original service, empowering researchers with on demand insights into clinical trials to help drive therapeutic decisions

Medical device manufacturer medi® USA announced the launch of its latest innovative knee-high compression sock, duomed relax.

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2019 financial results in a press release on Tuesday, May 7, 2019 before the market opens and to host a conference call on the results at 9 a.m. MT / 11 a.m. ET on the same day.

Viracta Therapeutics, Inc. announced that theU.S. Food & Drug Administration (FDA) has granted Orphan Drug Designations (ODD) to their Phase 2 drug candidate, nanatinostat, in combination with the antiviral valganciclovir, for the treatment of post-transplant lymphoproliferative disorder (PTLD), plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma.

Lifestyle Delivery Systems Inc. announces that its flagship product, CannaStrips™, will be featured at two separate cannabis events over the 4/20 Cannabis holiday weekend.

Fullerton Healthcare Corporation Limited (“Fullerton Health”), a leading vertically integrated healthcare platform in the Asia Pacific region with a proven track record of providing clients with seamless service offerings through customized healthcare management and administration, has partnered with Health Catalyst,

AAC Holdings, Inc. announced financial results for the fourth quarter and year ended December 31, 2018, as well as 2019 guidance.